TrialDrug design, development and therapy2015

A phase 1 randomized study evaluating the effect of omeprazole on the pharmacokinetics of a novel 5-hydroxytryptamine receptor 4 agonist, revexepride (SSP-002358), in healthy adults.

David Pierce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.